{"result": {"id": "17963f6d-73da-42be-9bf9-38959b719894", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>2型糖尿病患者<|>PERSON<|>Patients with type 2 diabetes who require medication and lifestyle management\")  \n##\n(\"entity\"<|>二甲双胍<|>ORGANIZATION<|>Metformin, the first-line medication for most type 2 diabetes patients\")  \n##\n(\"entity\"<|>胰岛素<|>ORGANIZATION<|>Insulin, used for diabetes treatment when oral medications are insufficient\")  \n##\n(\"entity\"<|>糖尿病肾病<|>EVENT<|>Diabetic kidney disease, a complication of diabetes affecting kidney function\")  \n##\n(\"entity\"<|>心力衰竭<|>EVENT<|>Heart failure, a condition that influences diabetes medication choices\")  \n##\n(\"relationship\"<|>2型糖尿病患者<|>二甲双胍<|>Most type 2 diabetes patients are initially treated with metformin<|>8)  \n##\n(\"relationship\"<|>2型糖尿病患者<|>胰岛素<|>Insulin is used when oral medications fail to control blood sugar<|>7)  \n##\n(\"relationship\"<|>糖尿病肾病<|>SGLT2I<|>SGLT2 inhibitors help slow progression of diabetic kidney disease<|>9)  \n##\n(\"relationship\"<|>心力衰竭<|>SGLT2I<|>SGLT2 inhibitors provide benefits for heart failure patients<|>8)  \n##\n(\"relationship\"<|>二甲双胍<|>胰岛素<|>Metformin may be combined with insulin for better glucose control<|>6)  \n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751558672, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 346, "prompt_tokens": 2921, "total_tokens": 3267, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 2880}, "prompt_cache_hit_tokens": 2880, "prompt_cache_miss_tokens": 41}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ��合并肾脏病、严重眼底病等并发症患者 ,血糖控 制目标也应适当放宽 。基本原则是不发生低血糖和高 血糖急症。\n\n\n\n　　饮食调整的原则 :控制总热卡 ,碳水化合物占总热 量 55%~65% ;蛋白质不多于总热量 15% 。尽可能控 制体重在正常范围内 。在总热量不变的情况下 ,少食 多餐有利于血糖控制和避免低血糖。\n　　运动和活动的原则 :适量、经常性和个体化 。推荐 骨骼肌等张运动项目 ,例如步行、游泳等 ,避免剧烈运 动项目和运动量过大 。接受胰岛素治疗的患者 ,强调 规律的生活 ,例如定时定量进餐和运动。\n药物治疗的主要原则[336-338]  :\n　　　(1) 大多数 2型糖尿病患者 ,首选二甲双胍 。体重 偏瘦或单用二甲双胍不能有效控制血糖者 ,改用或加 用其他降糖药。\n　　　(2)对 HbA1c水平高于治疗靶目标水平 1.5%~ 2.0%的患者 ,应考虑初始即联合降糖药治疗。\n　　　(3)并发症和合并症是 2型糖尿病患者选择降糖 药的重要依据 。合并 ASCVD或心血管风险高危的患 者 ,无论其 HbA1c是否达标 ,只要没有禁忌证都应使 用具有心血管获益证据的 GLP-1RA或 SGLT2i。合 并 CKD或心力衰竭的患者 , 无论其 HbA1c是否达 标 ,只要没有禁忌证都应使用 SGLT2i。\n　　　(4) 对 合 并 肾 脏 疾 病 的 患 者 , 推 荐 在 eGFR≥ 30mL/(min · 1.73 m2) 时使用 SGLT2i, 以降低糖尿 病肾病进展和/或心血管事件的风险 。GLP-1RA 能 减少糖尿病患者新发大量蛋白尿的风险 ,可以考虑在 eGFR≥30mL/(min · 1.73 m2) 的患者中使用 。 肾功 能不全的患者可优先选择从肾脏排泄较少的降糖药 , 严重肾功能不全的患者宜采用胰岛素治疗。\n　　　(5)采用 2种中等以上剂量降糖药而仍难以控制 血糖者 ,可采用口服降糖药加用一天一次基础胰岛素 (中效或超长效胰岛素或其类似物) 治疗 ;或在口服降 糖药加基础胰岛素联合治疗前 ,先用口服降糖药联合 GLP-1RA治疗 , 每周 1 次注射的周制剂较每日注射 1~2次的 GLP-1RA制剂更容易为患者所接受 。如果 仍不能有效控制血糖 , 可采用 一 日多次胰岛素注射 治疗。\n　　　(6) 空腹血糖>11 mmol/L或 HbA1c≥9%同时 伴明显高血糖症状的新诊断 2 型糖尿病患者 ,可考虑\n######################\nOutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>ASCVD<|>EVENT<|>Atherosclerotic cardiovascular disease, a condition that increases cardiovascular risk in patients with diabetes\")  \n##\n(\"entity\"<|>CKD<|>EVENT<|>Chronic kidney disease, a condition that affects kidney function and is common in diabetes patients\")  \n##\n(\"entity\"<|>GLP-1RA<|>ORGANIZATION<|>Glucagon-like peptide-1 receptor agonists, a class of diabetes medications with cardiovascular benefits\")  \n##\n(\"entity\"<|>SGLT2I<|>ORGANIZATION<|>Sodium-glucose cotransporter-2 inhibitors, a class of diabetes medications beneficial for heart and kidney health\")  \n##\n(\"entity\"<|>HBA1C<|>EVENT<|>Glycated hemoglobin, a measure of long-term blood glucose control\")  \n##\n(\"entity\"<|>EFFR<|>EVENT<|>Estimated glomerular filtration rate, a measure of kidney function\")  \n##\n(\"relationship\"<|>GLP-1RA<|>ASCVD<|>GLP-1RA is recommended for patients with ASCVD due to its cardiovascular benefits<|>7)  \n##\n(\"relationship\"<|>SGLT2I<|>CKD<|>SGLT2i is recommended for patients with CKD to reduce kidney disease progression<|>8)  \n##\n(\"relationship\"<|>GLP-1RA<|>SGLT2I<|>Both are recommended for diabetes patients with specific complications<|>5)  \n##\n(\"relationship\"<|>HBA1C<|>GLP-1RA<|>HbA1c levels influence the decision to use GLP-1RA in diabetes treatment<|>6)  \n##\n(\"relationship\"<|>EFFR<|>SGLT2I<|>eGFR determines eligibility for SGLT2i use in kidney disease patients<|>7)  \n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_extract-continuation-0_2c2ac392590ba98f9e8aee575964074df8ee1b792caad0f27085962d5726f8aa_v2"}